Genetically, lesion-confined mTOR-pathway mosaicism accounts for a substantial subset of FCD type II, while SLC35A2 mutations underlie mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). The gene discussed is SLC35A2; the disease is isolated focal cortical dysplasia type II.